Pediatric Diarrhea Patients Living in Urban Areas Have Higher Incidence of Clostridioides difficile Infection

Clostridioides difficile infection (CDI) is a major cause of antibiotic-associated diarrhea and an unappreciated contributor to child mortality in low- and middle-income countries where diagnosis may be difficult. There is little information about the prevalence of CDI among infants, children, and adolescents in Africa. Seventy-six samples were collected from pediatric patients presenting with diarrhea, including infants (<= 2 years old), children (2-12 years) and adolescents (13 <=17 years) from three hospitals between January and December 2019. Demographic data, medical history and prior antibiotic use were recorded. Toxigenic culture and PCR were used to detect and validate the presence of C. difficile in the samples. A total of 29 (38.7%), 39 (52.0%) and 7 (9.3%) samples were from infants, children, and adolescents, respectively. Average age of the patients was 4.4 years. Of these samples, 31 (41%) were positive for C. difficile by culture and were verified by PCR amplification of C. difficile specific genes (tcdA and tcdB). Most positive cases were children (53.3%) and infants (40.0%) with the majority of them residing in the urban areas. Forty-nine (66.2%) of the patients had no known antibiotics exposure, whereas 29.0% and 29.7% reported use of over-the-counter antibiotics at 14 and 90 days, prior to the hospital visit, respectively. CDI is relatively common among children with diarrhea in Northern Nigeria. Therefore, for effective management and treatment, more attention should be given to testing for C. difficile as one of the causative agents of diarrhea.


Introduction
Clostridioides difficile is a strict anaerobic Gram-positive bacterium that colonizes up to 15% of 66 healthy people [1]. It is a major cause of antibiotic-associated diarrhea worldwide, whereby 67 antibiotic treatment reduces the abundance of competing gut microbiota, allowing C. difficile to 68 proliferate and cause mild to severe diarrhea [2][3][4]. 69 The toxins (enterotoxin A and cytotoxin B) released during C. difficile infection (CDI) cause tissue 70 damage [5]. These two toxins, encoded by the tcdA and tcdB, are located within a 19.6 kbp 71 pathogenicity locus. Older age, antibiotic usage, gastric acid-suppressing drugs, inflammatory 72 bowel disease, gastrointestinal surgery, use of naso, gastric tubes, neoplastic disease, 73 immunodeficiency, and comorbidities are risk factors for CDI [6]. 74 The United States Center for Disease Control and Prevention (CDC) in 2019 declared C. difficile as 75 one of the five 'urgent health threats' because of the significant risk associated with antibiotic 76 use [7]. Despite this urgency, prevalence of CDI in low and middle-income countries is 77 underestimated. In developing nations where self-medication occurs frequently, higher 78 incidence of CDI may be expected. Outbreak of CDI in developed countries have increased 79 vigilance in these countries but little is known about CDI in Nigeria [8]. Adegboyega.
[9] and 80 Doughari et al. [10] found C. difficile spores and the bacterium, respectively, from samples 81 obtained from hospital environments. Oguike and Emeruwa [11] isolated C. difficile from 156 82 (48.8%) out of 320 stool samples collected from infants under the age of 5 years and confirmed 83 occurrence of cytotoxin production from 25 (14.8%) of the isolates. Onwueme et al., [12] 84 reported that among 71 HIV out-patients at one hospital, 10 (14.1%) and 61 (85.9%) of C. difficile 85 isolates were toxin positive and toxin negative, respectively. 86 Normally, CDI testing in developing countries is not routine owing to the lack of resources for 87 diagnosis and culture facilities for obligate anaerobes [13]. This is unfortunate because majority 88 of global mortality among children in the first 5 years of their life is due to diarrhea, of which a 89 potentially large proportion could involve CDI [14,15]. Limited testing also translates into a low 90 index of clinical suspicion that exacerbates the lack of effort towards diagnostic screening [16,91 12] resulting in misdiagnosis and incorrect treatment. The lack of information about CDI is also 92 problematic because most African countries are popular tourist destinations and may serve as 93 incubators of CDI [17]. 94 In most African countries, antimicrobials are easily accessed over-the-counter (OTC) [18][19][20]. 95 There is also high incidence of community-and nosocomial-associated diarrhea among children 96 [20,21], but few data are available on incidence of CDI. Consequently, we initiated a survey to 97 estimate the occurrence of CDI among pediatric diarrheic outpatients (0 -17 years) in Katsina 98 State, Nigeria. 99 100 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 20, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022  Primer specific for toxin A and B were used to assess the presence of these genes while a 16S 135 ribosomal marker (16S rRNA) served as a positive control for the PCR reaction [24][25][26][27][28][29]15]. The 136 primer sequences used were as follows: TcdA2 (F-5'AGATTCCTATATTTACATGACAATAT3', R-. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 20, 2022. ;

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 20, 2022. between CDI incidence in their study compared to urban-based estimates. 224 We confirmed toxins A and B production in the isolates, suggesting that infants and children can 225 be reservoirs of clinically relevant strains of C. difficile. The study also showed that younger 226 children can have longer diarrheal periods and hospitalization than older children. This may be 227 related to the immune system, since infants and children still have compromised immune 228 systems compared to adolescents [34]. As a result, the diarrhea could be quickly resolved in 229 adolescents than infants and children. Also, it been reported that the prevalence of C. difficile 230 colonization in neonate ranges from 2% to 50% with colonization often occurring within the first 231 week of life [35]. In contrast to adults where the rate of colonization in community and hospital 232 settings is 3% and 20%, respectively. 233 Our study has some limitations that warrants cautious interpretation of the findings. First, the 234 small sample size of participants stemmed from the fact that only diarrheal patients who 235 reported to the hospitals were screened by the attending physicians. Consequently, this non-236 random sampling method placed some constraints on the generalizability of our findings, 237 especially as some patients who had diarrhea may not have reported to the hospitals. Second, 238 the survey was self-reported, and thus, some participants may have exhibited social desirability 239 and recall biases in their responses. Finally, the presence of other diarrhea-causing pathogen was 240 not tested in this study and will be the subject of our on-going research in this population. 241 In conclusion, attention should be given to testing for C. difficile as one of the causes of diarrhea 242 during diagnosis rather than simply administrating antibiotics empirically. Testing can also 243 promote development and implementation of strategies that regulate antimicrobials known to 244 induce community and hospital acquired CDI. As this is the first report of CDI in northern part of 245 Nigeria, future work will include examining the diversity of strains as well as other phenotypic 246 and virulence-associated characteristics.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 20, 2022. WHO and UNICEF Global, regional, and national causes of child mortality: an updated . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 20, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 20, 2022. ;https://doi.org/10.1101/2022 T., Harding, R.M., Jeffery, K.J., Jolley, K.A. and Kirton, R., 2010 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 20, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 20, 2022. ; is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 20, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 20, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022